Please assess the completion status of the following clinical trial:

Trial Title: A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes mellitus~* Drug naive~* Hemoglobin A1c (HbA1c) ≥6.0% and ≤8.0%~* Fasting C-peptide ≥1.0 ng/mL~* Body mass index ≤40 kg/m²~Exclusion Criteria:~* Recent cardiac or cerebrovascular event~* Elevated serum creatinine

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Saxagliptin (A) (Type: EXPERIMENTAL): Metformin 500-1500 mg (open-label, as needed for rescue in LT)
- Placebo (ST) / Metformin (LT) (B) (Type: PLACEBO_COMPARATOR): Metformin 500-1500 mg (open-label, as needed for rescue in LT)

Based on this trial design, predict the completion outcome and termination type (if applicable).